- Diapered toddler crashes Jeep, runs home to watch cartoons
- Obama’s post re-election stats irk: 81 golf rounds, 75 fundraisers
- Number-crunchers put GOP chances of retaking Senate at 60 percent: report
- Ohio sheriff sends bill to Mexico for cost of jailing illegals
- Fla. voters’ support for medical marijuana bodes well for ballot measure: poll
- Keith Urban concert ends in ‘nutso’ chaos, with dozens arrested, injured
- Very religious still lean toward GOP, reflecting long-term patterns, Gallup poll shows
- Fist bump becoming all the rage for germ-wary handshakers
- Tennessee storms ravage counties, wreck 10 homes
- Chinese police tear down church cross in religion crackdown
Myriad Genetics Inc.
Latest Myriad Genetics Inc. Items
The Supreme Court seemed worried Monday about the idea of companies patenting genes that can be found inside the human body, as it heard arguments in a case that could profoundly reshape U.S. medical research and the fight against diseases such as breast and ovarian cancer.
The Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers.